Catalyst

Slingshot members are tracking this event:

LifeWatch receives FDA clearance for its Mobile Cardiac Telemetry 1-Lead Patch

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SIX:LIFE

100%

Additional Information

Additional Relevant Details This latest clearance, when combined with the recently obtained CE mark, enables LifeWatch to provide patients in many parts of the globe with a new diagnostic monitoring patch alternative. The MCT 1-Lead Patch is capable of watching every heartbeat for adverse cardiac events and transmitting significant findings, in near real time, to a clinical service center for immediate follow-up. The MCT 1-Lead Patch technology is an easy to use, discrete and lightweight alternative to traditional recording and transmitting devices. It is significantly more comfortable for the patient and should therefore lead to an increase in the diagnostic yield as a result of improved patient compliance.
http://www.irlifewat...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 18, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Mct 1-lead Patch, Cardiac Diagnostic Monitoring, Remote Diagnostic Monitoring Devices